Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Upadacitinib Treatment Patterns, Achievement of Treatment Targets and Maintenance of Response in Moderate to Severe Rheumatoid Arthritis Patients in Real-World Practice (UPHOLD)

NCT04497597 is registered in ClinicalTrials.gov with AbbVie as lead sponsor.

NCT NCT04497597
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04497597 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Upadacitinib Treatment Patterns, Achievement of Treatment Targets and Maintenance of Response in Moderate to Severe Rheumatoid Arthritis Patients in Real-World Practice (UPHOLD)
Lead sponsor
AbbVie
Phase
Observational
Overall status
Completed
Start date
October 16, 2020
Completion date
May 15, 2024
Enrollment
1,532 (actual)
Sites
263

Conditions

As the registry lists them; a condition with its own page is linked.

rheumatoid arthritis (ra)